ARTICLE | Company News
Labopharm signs second agreement with Aventis
September 12, 2000 7:00 AM UTC
Labopharm (TSE:DDS) signed an agreement with Aventis (AVE) to develop two formulations of a marketed product from AVE. In August, DDS and AVE also agreed to develop two formulations of a marketed AVE ...